Logo image of MARV.CA

MARVEL DISCOVERY CORP (MARV.CA) Stock Fundamental Analysis

Canada - TSX-V:MARV - CA57383V1085 - Common Stock

0.03 CAD
0 (0%)
Last: 3/4/2025, 7:00:00 PM
Fundamental Rating

1

MARV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 807 industry peers in the Metals & Mining industry. While MARV seems to be doing ok healthwise, there are quite some concerns on its profitability. MARV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MARV has reported negative net income.
In the past year MARV has reported a negative cash flow from operations.
In the past 5 years MARV always reported negative net income.
MARV had a negative operating cash flow in each of the past 5 years.
MARV.CA Yearly Net Income VS EBIT VS OCF VS FCFMARV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -500K -1M -1.5M -2M

1.2 Ratios

MARV has a Return On Assets (-20.63%) which is comparable to the rest of the industry.
MARV has a Return On Equity (-27.76%) which is in line with its industry peers.
Industry RankSector Rank
ROA -20.63%
ROE -27.76%
ROIC N/A
ROA(3y)-25.78%
ROA(5y)-21.56%
ROE(3y)-34.73%
ROE(5y)-29.39%
ROIC(3y)N/A
ROIC(5y)N/A
MARV.CA Yearly ROA, ROE, ROICMARV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MARV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MARV.CA Yearly Profit, Operating, Gross MarginsMARV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

4

2. Health

2.1 Basic Checks

MARV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MARV has been increased compared to 5 years ago.
There is no outstanding debt for MARV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MARV.CA Yearly Shares OutstandingMARV.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
MARV.CA Yearly Total Debt VS Total AssetsMARV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

2.2 Solvency

MARV has an Altman-Z score of -2.38. This is a bad value and indicates that MARV is not financially healthy and even has some risk of bankruptcy.
MARV has a Altman-Z score of -2.38. This is comparable to the rest of the industry: MARV outperforms 40.15% of its industry peers.
MARV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.38
ROIC/WACCN/A
WACCN/A
MARV.CA Yearly LT Debt VS Equity VS FCFMARV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

MARV has a Current Ratio of 0.29. This is a bad value and indicates that MARV is not financially healthy enough and could expect problems in meeting its short term obligations.
MARV has a worse Current ratio (0.29) than 72.38% of its industry peers.
MARV has a Quick Ratio of 0.29. This is a bad value and indicates that MARV is not financially healthy enough and could expect problems in meeting its short term obligations.
MARV has a worse Quick ratio (0.29) than 71.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
MARV.CA Yearly Current Assets VS Current LiabilitesMARV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K

More info and screens

0

3. Growth

3.1 Past

MARV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -173.33%.
EPS 1Y (TTM)-173.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1500%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MARV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MARV.CA Price Earnings VS Forward Price EarningsMARV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MARV.CA Per share dataMARV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MARV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARVEL DISCOVERY CORP

TSX-V:MARV (3/4/2025, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-21 2025-02-21
Earnings (Next)04-28 2025-04-28
Inst Owners9.54%
Inst Owner ChangeN/A
Ins Owners8.73%
Ins Owner ChangeN/A
Market Cap4.41M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.63%
ROE -27.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-25.78%
ROA(5y)-21.56%
ROE(3y)-34.73%
ROE(5y)-29.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -2.38
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-173.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1500%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.13%
OCF growth 3YN/A
OCF growth 5YN/A